Table 3.
Effect of propolis on hepatorenal biochemical assay against carbon tetrachloride intoxication. (Values are mean ± SE from six rats in each group.)
| Groups | Total protein contents | Glycogen contents | Triglycerides | |||
|---|---|---|---|---|---|---|
| (mg/100 mg) | (mg/100 g) | (mg/100 mg) | ||||
| Hepatic | Renal | Hepatic | Renal | Hepatic | Renal | |
| Control | 15.7 ± 0.86 | 15.1 ± 0.83 | 2700 ± 149 | 84.0 ± 4.64 | 3.20 ± 0.17 | 2.95 ± 0.16 |
| CCl4 | 12.3 ± 0.67# | 13.1 ± 0.72# | 984 ± 54.3# | 51.1 ± 2.81# | 8.30 ± 0.45# | 6.78 ± 0.37# |
| CCl4 + Propolis | 15.3 ± 0.84* | 14.1 ± 0.77* | 2128 ± 117* | 79.0 ± 4.36* | 3.80 ± 0.21* | 3.37 ± 0.18* |
| % Protection | 88.2% | 50.0% | 66.6% | 84.8% | 88.2% | 89.1% |
| CCl4 + Silymarin | 15.4 ± 0.85* | 14.3 ± 0.79* | 2240 ± 123* | 81.0 ± 4.47* | 3.60 ± 0.19* | 3.58 ± 0.19* |
| % Protection | 91.1% | 60.0% | 73.1% | 90.9% | 92.2% | 83.5% |
|
| ||||||
| F Variance | 4.58† | 1.32 | 46.9† | 163† | 84.6† | 61.6† |
P value CCl4 versus control at #≤0.05; therapy versus CCl4 at ∗ ≤ 0.05; †significant for analysis of variance P ≤ 0.05.